The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
8016617 8317508 I 8016617-1 20110926 20111223 20111231 EXP CHPA2011GB018718 NOVARTIS CONSUMER HEALTH, INC. 0 YR Y 3.43 KG 20111231 CN UNITED KINGDOM

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
8016617 1018419886 PS FERROUS SULFATE TAB 1 TRANSPLACENTAL UNK, UNK
8016617 1018419887 SS TYPHIM VI 1 TRANSPLACENTAL 1 DF, ONCE/SINGLE G0069

Indications of drugs used

Event ID DRUG SEQ INDI PT
8016617 1018419887 IMMUNISATION

Outcome of event

Event ID OUTC COD
8016617 CA

Reactions reported

Event ID PT
8016617 FOETAL EXPOSURE DURING PREGNANCY
8016617 SYNDACTYLY

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
8016617 1018419886 20110515
8016617 1018419887 20110415 20110415 1 DAY